Shutsung Liao - Publications

University of Chicago, Chicago, IL 
Cell Biology, Molecular Biology

35 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Kokontis JM, Lin HP, Jiang SS, Lin CY, Fukuchi J, Hiipakka RA, Chung CJ, Chan TM, Liao S, Chang CH, Chuu CP. Androgen suppresses the proliferation of androgen receptor-positive castration-resistant prostate cancer cells via inhibition of Cdk2, CyclinA, and Skp2. Plos One. 9: e109170. PMID 25271736 DOI: 10.1371/journal.pone.0109170  0.52
2014 Kokontis JM, Lin HP, Jiang SS, Lin CY, Fukuchi J, Hiipakka RA, Chung CJ, Chan TM, Liao S, Chang CH, Chuu CP. Correction: Androgen suppresses the proliferation of androgen receptor-positive castration-resistant prostate cancer cells via inhibition of Cdk2, CyclinA, and Skp2 (PLoS ONE (2014) 9, 10 (e109170) DOI: 10.1371/journal.pone.0109170) Plos One. 9. DOI: 10.1371/journal.pone.0111731  0.52
2012 Chuu CP, Lin HP, Ciaccio MF, Kokontis JM, Hause RJ, Hiipakka RA, Liao S, Jones RB. Caffeic acid phenethyl ester suppresses the proliferation of human prostate cancer cells through inhibition of p70S6K and Akt signaling networks. Cancer Prevention Research (Philadelphia, Pa.). 5: 788-97. PMID 22562408 DOI: 10.1158/1940-6207.CAPR-12-0004-T  0.52
2011 Chuu CP, Kokontis JM, Hiipakka RA, Fukuchi J, Lin HP, Lin CY, Huo C, Huo C, Su LC, Liao S. Androgen suppresses proliferation of castration-resistant LNCaP 104-R2 prostate cancer cells through androgen receptor, Skp2, and c-Myc. Cancer Science. 102: 2022-8. PMID 21781227 DOI: 10.1111/j.1349-7006.2011.02043.x  0.52
2011 Peng L, Hiipakka RA, Xie JT, Kokontis JM, Liao S, Peng D. The effect of diet on the response of low-density lipoprotein receptor knockout mice to the liver X receptor agonist T1317. Journal of Cardiovascular Pharmacology. 58: 102-10. PMID 21558881 DOI: 10.1097/FJC.0b013e31821d1168  0.52
2011 Peng D, Hiipakka RA, Xie JT, Dai Q, Kokontis JM, Reardon CA, Getz GS, Liao S. A novel potent synthetic steroidal liver X receptor agonist lowers plasma cholesterol and triglycerides and reduces atherosclerosis in LDLR(-/-) mice. British Journal of Pharmacology. 162: 1792-804. PMID 21232031 DOI: 10.1111/j.1476-5381.2011.01202.x  0.52
2010 Lin SF, Lin YH, Lin M, Kao YF, Wang RW, Teng LW, Chuang SH, Chang JM, Yuan TT, Fu KC, Huang KP, Lee YS, Chiang CC, Yang SC, Lai CL, ... ... Liao S, et al. Synthesis and structure-activity relationship of 3-O-acylated (-)-epigallocatechins as 5α-reductase inhibitors. European Journal of Medicinal Chemistry. 45: 6068-76. PMID 21044810 DOI: 10.1016/j.ejmech.2010.10.011  0.52
2010 Guo J, Peng D, Dai Q, Liao S, Wright BJ, van Breemen RB. Quantitative analysis of 3alpha,6alpha,24-trihydroxy-24,24-di(trifluoromethyl)-5beta-cholane, a potent synthetic steroidal liver X receptor agonist in plasma using liquid chromatography-tandem mass spectrometry. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 878: 1885-8. PMID 20627826 DOI: 10.1016/j.jchromb.2010.05.009  0.52
2010 Peng D, Hiipakka RA, Xie JT, Reardon CA, Getz GS, Liao S. Differential effects of activation of liver X receptor on plasma lipid homeostasis in wild-type and lipoprotein clearance-deficient mice. Atherosclerosis. 208: 126-33. PMID 19632679 DOI: 10.1016/j.atherosclerosis.2009.07.016  0.52
2009 Tang F, Kokontis J, Lin Y, Liao S, Lin A, Xiang J. Androgen via p21 inhibits tumor necrosis factor alpha-induced JNK activation and apoptosis. The Journal of Biological Chemistry. 284: 32353-8. PMID 19723627 DOI: 10.1074/jbc.M109.042994  0.48
2009 Chuu CP, Chen RY, Kokontis JM, Hiipakka RA, Liao S. Suppression of androgen receptor signaling and prostate specific antigen expression by (-)-epigallocatechin-3-gallate in different progression stages of LNCaP prostate cancer cells. Cancer Letters. 275: 86-92. PMID 18977589 DOI: 10.1016/j.canlet.2008.10.001  0.52
2009 Peng D, Hiipakka RA, Reardon CA, Getz GS, Liao S. Differential anti-atherosclerotic effects in the innominate artery and aortic sinus by the liver X receptor agonist T0901317. Atherosclerosis. 203: 59-66. PMID 18639878 DOI: 10.1016/j.atherosclerosis.2008.05.058  0.52
2008 Peng D, Hiipakka RA, Dai Q, Guo J, Reardon CA, Getz GS, Liao S. Antiatherosclerotic effects of a novel synthetic tissue-selective steroidal liver X receptor agonist in low-density lipoprotein receptor-deficient mice. The Journal of Pharmacology and Experimental Therapeutics. 327: 332-42. PMID 18723776 DOI: 10.1124/jpet.108.142687  0.52
2007 Chuu CP, Chen RY, Hiipakka RA, Kokontis JM, Warner KV, Xiang J, Liao S. The liver X receptor agonist T0901317 acts as androgen receptor antagonist in human prostate cancer cells. Biochemical and Biophysical Research Communications. 357: 341-6. PMID 17416342 DOI: 10.1016/j.bbrc.2007.03.116  0.52
2007 Chuu CP, Kokontis JM, Hiipakka RA, Liao S. Modulation of liver X receptor signaling as novel therapy for prostate cancer. Journal of Biomedical Science. 14: 543-53. PMID 17372849 DOI: 10.1007/s11373-007-9160-8  0.52
2006 Chuu CP, Hiipakka RA, Kokontis JM, Fukuchi J, Chen RY, Liao S. Inhibition of tumor growth and progression of LNCaP prostate cancer cells in athymic mice by androgen and liver X receptor agonist. Cancer Research. 66: 6482-6. PMID 16818617 DOI: 10.1158/0008-5472.CAN-06-0632  0.52
2006 Lin Y, Kokontis J, Tang F, Godfrey B, Liao S, Lin A, Chen Y, Xiang J. Androgen and its receptor promote Bax-mediated apoptosis. Molecular and Cellular Biology. 26: 1908-16. PMID 16479009 DOI: 10.1128/MCB.26.5.1908-1916.2006  0.52
2005 Kokontis JM, Hsu S, Chuu CP, Dang M, Fukuchi J, Hiipakka RA, Liao S. Role of androgen receptor in the progression of human prostate tumor cells to androgen independence and insensitivity. The Prostate. 65: 287-98. PMID 16015608 DOI: 10.1002/pros.20285  0.52
2005 Fukuchi J, Song C, Dai Q, Hiipakka RA, Liao S. 5beta-Cholane activators of the farnesol X receptor. The Journal of Steroid Biochemistry and Molecular Biology. 94: 311-8. PMID 15857750 DOI: 10.1016/j.jsbmb.2004.11.012  0.52
2005 Chuu CP, Hiipakka RA, Fukuchi J, Kokontis JM, Liao S. Androgen causes growth suppression and reversion of androgen-independent prostate cancer xenografts to an androgen-stimulated phenotype in athymic mice. Cancer Research. 65: 2082-4. PMID 15781616 DOI: 10.1158/0008-5472.CAN-04-3992  0.52
2004 Fukuchi J, Kokontis JM, Hiipakka RA, Chuu CP, Liao S. Antiproliferative effect of liver X receptor agonists on LNCaP human prostate cancer cells. Cancer Research. 64: 7686-9. PMID 15520170 DOI: 10.1158/0008-5472.CAN-04-2332  0.52
2004 Fukuchi J, Hiipakka RA, Kokontis JM, Hsu S, Ko AL, Fitzgerald ML, Liao S. Androgenic suppression of ATP-binding cassette transporter A1 expression in LNCaP human prostate cancer cells. Cancer Research. 64: 7682-5. PMID 15520169 DOI: 10.1158/0008-5472.CAN-04-2647  0.52
2004 Fukuchi J, Hiipakka RA, Kokontis JM, Nishimura K, Igarashi K, Liao S. TATA-binding protein-associated factor 7 regulates polyamine transport activity and polyamine analog-induced apoptosis. The Journal of Biological Chemistry. 279: 29921-9. PMID 15078871 DOI: 10.1074/jbc.M401078200  0.52
2003 Fukuchi J, Song C, Ko AL, Liao S. Transcriptional regulation of farnesyl pyrophosphate synthase by liver X receptors. Steroids. 68: 685-91. PMID 12957674  0.36
2002 Hiipakka RA, Zhang HZ, Dai W, Dai Q, Liao S. Structure-activity relationships for inhibition of human 5alpha-reductases by polyphenols. Biochemical Pharmacology. 63: 1165-76. PMID 11931850 DOI: 10.1016/S0006-2952(02)00848-1  0.52
2001 Liao S, Lin J, Dang MT, Zhang H, Kao YH, Fukuchi J, Hiipakka RA. Growth suppression of hamster flank organs by topical application of catechins, alizarin, curcumin, and myristoleic acid Archives of Dermatological Research. 293: 200-205. PMID 11380153 DOI: 10.1007/s004030000203  0.52
2001 Kokontis JM, Wagner AJ, O'leary M, Liao S, Hay N. A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function Oncogene. 20: 659-668. PMID 11313999 DOI: 10.1038/sj.onc.1204139  0.52
1990 Liang T, Hiipakka RA, Stebbins J, Liao S. Anti-5α-reductase autoantibodies in the serum of patients with prostatic cancer Journal of Clinical Endocrinology and Metabolism. 71: 1666-1668. PMID 2229323 DOI: 10.1210/jcem-71-6-1666  0.52
1985 Goueli SA, Davis AT, Hiipakka RA, Liao S, Ahmed K. Polyamine-stimulated phosphorylation of prostatic spermine-binding protein is mediated only by cyclic AMP-independent protein kinases. The Biochemical Journal. 230: 293-302. PMID 2996498 DOI: 10.1042/bj2300293  0.52
1984 Hiipakka RA, Chen C, Schilling K, Oberhauser A, Saltzman A, Liao S. Immunochemical characterization of the androgen-dependent spermine-binding protein of the rat ventral prostate. The Biochemical Journal. 218: 563-71. PMID 6712632 DOI: 10.1042/bj2180563  0.52
1971 Liao S, Lin AH, Tymoczko JL. Adenyl cyclase of cell nuclei isolated from rat ventral prostate Bba - General Subjects. 230: 535-538. PMID 4325678 DOI: 10.1016/0304-4165(71)90185-1  0.52
1969 Liao S, Sagher D, Lin AH, Fang S. Magnesium and manganese specific forms of soluble liver RNA polymerase Nature. 223: 297-298. DOI: 10.1038/223297a0  0.52
1968 Anderson KM, Liao S. Selective retention of dihydrotestosterone by prostatic nuclei (19) Nature. 219: 277-279. PMID 5671431 DOI: 10.1038/219277a0  0.52
1968 Liao S. Evidence for a discriminatory action of androgenic steroids on the synthesis of nucleolar ribonucleic acids in prostatic nuclei Integrative and Comparative Biology. 8: 233-242. DOI: 10.1093/icb/8.2.233  0.52
1966 Liao S, Barton RW, Lin AH. Differential synthesis of ribonucleic acid in prostatic nuclei: evidence for selective gene transcription induced by androgens Proceedings of the National Academy of Sciences of the United States of America. 55: 1593-1600. PMID 5227677 DOI: 10.1073/pnas.55.6.1593  0.52
Show low-probability matches.